Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. - Concepedia

Concepedia

Publication | Closed Access

Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial.

94

Citations

0

References

2002

Year

Andrew D Michaels, Mark Appleby, Matthew H Otten, Kent W. Dauterman, Thomas A. Ports, Tony M. Chou, C Michael Gibson

Abstract

Intragraft administration of verapamil prior to saphenous vein graft PCI reduces no-reflow and is associated with a trend toward improved myocardial perfusion.